Dement Neurocogn Disord.  2018 Mar;17(1):32-36. 10.12779/dnd.2018.17.1.32.

Hydrocephalus in a Patient with Alzheimer's Disease

Affiliations
  • 1Department of Neurology, Seoul National University Bundang Hospital, Seongnam, Korea.
  • 2Department of Neurology, Wonkwang University School of Medicine, Iksan, Korea. md0626@naver.com

Abstract

BACKGROUND
Normal pressure hydrocephalus (NPH) is an etiology of dementia that is reversible following cerebrospinal fluid shunt placement, however, surgical intervention not always clinically effective and the respons to shunt therapy is poorly understood. Furthermore, NPH is a source of comorbidity in diseases with neurodegenerative pathology, such as Alzheimer's disease (AD).
CASE REPORT
A 61-year-old woman presented to the neurology clinic with progressive gait difficulties and cognitive impairment over five years. Nine years after ventriculoperitoneal (VP) shunt treatment, the patient began to experience frequent falls. There was no improvement in clinical symptoms after the alteration of valve pressure on the VP shunt. An 18F-florbetaben amyloid positron emission tomography scan showed increased diffusion uptake over the bilateral cortices, precuneus, and posterior cingulate cortex.
CONCLUSIONS
The patient of NPH was unresponsive to shunt therapy due to the development of AD.

Keyword

Hydrocephalus; Alzheimer Disease; Amyloid

MeSH Terms

Accidental Falls
Alzheimer Disease*
Amyloid
Cerebrospinal Fluid Shunts
Cognition Disorders
Comorbidity
Dementia
Diffusion
Female
Gait
Gyrus Cinguli
Humans
Hydrocephalus*
Hydrocephalus, Normal Pressure
Middle Aged
Neurology
Parietal Lobe
Pathology
Positron-Emission Tomography
Amyloid

Figure

  • Fig. 1 Brain magnetic resonance imaging at diagnosis and follow-up. Fluid-attenuated inversion recovery images showed severe ventriculomegaly at diagnosis (A). There is no change in ventriculomegaly 9 years after insertion of the ventriculoperitoneal shunt (B).

  • Fig. 2 Axial images from amyloid imaging with 18F-florbetaben. 18F-florbetaben amyloid positron emission tomography scan showing increased diffusion uptake over the bilateral cortices, precuneus, and posterior cingulate cortex.


Cited by  1 articles

The Impact of Comorbid Alzheimer's Disease in a Patient with Normal Pressure Hydrocephalus?
Halil Onder
Dement Neurocogn Disord. 2020;19(1):31-32.    doi: 10.12779/dnd.2020.19.1.31.


Reference

1. Hakim S, Adams RD. The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci. 1965; 2:307–327.
Article
2. Shprecher D, Schwalb J, Kurlan R. Normal pressure hydrocephalus: diagnosis and treatment. Curr Neurol Neurosci Rep. 2008; 8:371–376.
Article
3. Ishikawa M, Hashimoto M, Kuwana N, Mori E, Miyake H, Wachi A, et al. Guidelines for management of idiopathic normal pressure hydrocephalus. Neurol Med Chir (Tokyo). 2008; 48:Suppl. S23.
4. Wood JH, Bartlet D, James AE, Udvarhelyi GB. Normal pressure hydrocephalus: diagnosis and patient selection for shunt surgery. Neurology. 1974; 24:517–526.
Article
5. Golomb J, Wisoff J, Miller DC, Boksay I, Kluger A, Weiner H, et al. Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response. J Neurol Neurosurg Psychiatry. 2000; 68:778–781.
Article
6. Del Bigio MR, Cardoso ER, Halliday WC. Neuropathological changes in chronic adult hydrocephalus: cortical biopsies and autopsy findings. Can J Neurol Sci. 1997; 24:121–126.
Article
7. Savolainen S, Paljarvi L, Vapalahti M. Prevalence of Alzheimer's disease in patients investigated for presumed normal pressure hydrocephalus: a clinical and neuropathological study. Acta Neurochir (Wien). 1999; 141:849–853.
Article
8. Messert B, Wannamaker BB. Reappraisal of the adult hydrocephalus syndrome. Neurology. 1974; 24:224–231.
9. Huckman MS. Normal pressure hydrocephalus: evaluation of diagnostic and prognostic tests. AJNR Am J Neuroradiol. 1981; 2:385–395.
10. Malm J, Kristensen B, Stegmayr B, Fagerlund M, Koskinen LO. Three-year survival and functional outcome of patients with idiopathic adult hydrocephalus syndrome. Neurology. 2000; 55:576–578.
Article
11. Iddon JL, Pickard JD, Cross JJ, Griffiths PD, Czosnyka M, Sahakian BJ. Specific patterns of cognitive impairment in patients with idiopathic normal pressure hydrocephalus and Alzheimer's disease: a pilot study. J Neurol Neurosurg Psychiatry. 1999; 67:723–732.
Article
12. Savolainen S, Laakso MP, Paljärvi L, Alafuzoff I, Hurskainen H, Partanen K, et al. MR imaging of the hippocampus in normal pressure hydrocephalus: correlations with cortical Alzheimer's disease confirmed by pathologic analysis. AJNR Am J Neuroradiol. 2000; 21:409–414.
13. Jagust WJ, Friedland RP, Budinger TF. Positron emission tomography with [18F] fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementia. J Neurol Neurosurg Psychiatry. 1985; 48:1091–1096.
Article
14. Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D. Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis. Lancet Neurol. 2003; 2:506–511.
Article
Full Text Links
  • DND
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr